Clinical Trial Update: Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating stereotactic ablative radiotherapy for oligometastatic hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Yonsei University | Conditions: Oligometastasis Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN